Myelodysplastic syndromes can be treated with supportive therapy, drugs such as decitabine, chemotherapy and surgery such as allogeneic hematopoietic stem cell transplantation.
1. Supportive treatment: red blood cell transfusion can be used to treat severe anemia, platelet transfusion can be used to treat bleeding symptoms, and attention should be paid to preventing infections when granulocytopenia and deficiency are present.
2. Drugs: Erythropoietin and other drugs can improve the hematopoietic function of some patients, and demethylating drugs such as decitabine can change gene expression, reduce the amount of blood transfusion and improve the quality of life.
3. Chemotherapy: the treatment of patients with high prokaryotic cells, such as the application of adriamycin, cytarabine and so on.
4. Surgery: e.g. allogeneic hematopoietic stem cell transplantation, which is the only possible cure for myelodysplastic syndromes. It can be applied to the treatment of patients in the relatively high-risk group, especially those who are young, with increased primitive cells and those with poor prognostic chromosomal karyotypes.
Patients with myelodysplastic syndromes need to visit the hematology department of a hospital in a timely manner, follow the doctor’s instructions for treatment, and avoid self-medication.